作者
Ali Mobasheri, Armaghan Mahmoudian, Ursule Kalvaityte, Ilona Uzieliene, Christina E Larder, Michèle M Iskandar, Stan Kubow, Paulo Cesar Hamdan, Cyro Scala de Almeida Jr, Lacey J Favazzo, Luc JC van Loon, Pieter J Emans, Pérola G Plapler, Michael J Zuscik
发表日期
2021/11
来源
Current rheumatology reports
卷号
23
期号
11
页码范围
78
出版商
Springer US
简介
Purpose of Review
Osteoarthritis (OA) is the most common forms of arthritis in the general population, accounting for more pain and functional disability than any other musculoskeletal disease. There are currently no approved disease modifying drugs for OA. In the absence of effective pharmacotherapy, many patients with OA turn to nutritional supplements and nutraceuticals, including collagen derivatives. Collagen hydrolyzates and ultrahydrolyzates are terms used to describe collagens that have been broken down into small peptides and amino acids in the presence of collagenases and high pressure.
Recent Findings
This article reviews the relevant literature and serves as a White Paper on collagen hydrolyzates and ultrahydrolyzates as emerging supplements often advertised to support joint health in OA. Collagen hydrolyzates have demonstrated …
引用总数
20202021202220232024110125
学术搜索中的文章